Danhong Injection for the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis

ObjectiveDanhong Injection (DHI) has been widely used to treat various diseases in China for many years. The objective of this systematic review was to evaluate the efficacy of DHI combined with antihypertensive drugs for treatment of hypertensive nephropathy.MethodsSeven databases were searched fro...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: YiZhuo Li (Συγγραφέας), Shihai Yan (Συγγραφέας), Lichao Qian (Συγγραφέας), Lihua Wu (Συγγραφέας), Yawei Zheng (Συγγραφέας), Zhuyuan Fang (Συγγραφέας)
Μορφή: Βιβλίο
Έκδοση: Frontiers Media S.A., 2020-06-01T00:00:00Z.
Θέματα:
Διαθέσιμο Online:Connect to this object online.
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1a89b202eea949d6930a58cbbf457f3c
042 |a dc 
100 1 0 |a YiZhuo Li  |e author 
700 1 0 |a Shihai Yan  |e author 
700 1 0 |a Lichao Qian  |e author 
700 1 0 |a Lihua Wu  |e author 
700 1 0 |a Yawei Zheng  |e author 
700 1 0 |a Zhuyuan Fang  |e author 
245 0 0 |a Danhong Injection for the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis 
260 |b Frontiers Media S.A.,   |c 2020-06-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2020.00909 
520 |a ObjectiveDanhong Injection (DHI) has been widely used to treat various diseases in China for many years. The objective of this systematic review was to evaluate the efficacy of DHI combined with antihypertensive drugs for treatment of hypertensive nephropathy.MethodsSeven databases were searched from inception to September 21st, 2019. Randomized controlled trials comparing DHI combined with antihypertensive drugs versus antihypertensive drugs alone were extracted. The primary outcome was microalbuminuria (mALB). Secondary outcomes included systolic blood pressure (SBP), diastolic blood pressure (DBP), and serum creatinine (SCr).ResultsFifteen studies were included in the meta-analysis, which indicated that DHI combined with antihypertensive drugs has advantages compared with antihypertensive drugs alone for reducing mALB [weighted mean difference (WMD) = −12.86, 95% confidence interval (CI) (−14.72, −11.0), P < 0.01], lowering SBP [WMD = −2.84, 95% CI (−4.56, −1.12), P = 0.001] and DBP [WMD = −2.38, 95% CI (−4.34, −0.43), P = 0.017], and decreasing SCr [WMD = −40.45, 95% CI (−55.69, −25.21), P < 0.01].ConclusionThe combination of DHI with antihypertensive drugs appears to be more effective than antihypertensive drugs alone for treatment of hypertensive nephropathy. A moderate duration (≤4 weeks) of DHI administration is reasonable, and longer treatment with DHI should be avoided, according to the results of subgroup analysis. 
546 |a EN 
690 |a hypertensive nephropathy 
690 |a Danhong injection 
690 |a traditional Chinese medicine 
690 |a meta-analysis 
690 |a systematic review 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 11 (2020) 
787 0 |n https://www.frontiersin.org/article/10.3389/fphar.2020.00909/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/1a89b202eea949d6930a58cbbf457f3c  |z Connect to this object online.